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Background: The physical activity levels of adult patients with cystic fibrosis hospitalised for
an acute respiratory exacerbation is unknown.
Methods: A prospective observational study was undertaken. Physical activity levels were
measured for a 24-h period using an activity monitor (SenseWear Pro 3) during hospitalisation
for an acute respiratory exacerbation and one month post-discharge. Measures of exercise
tolerance and muscle strength were also recorded.
Results: Twenty-four patients completed the study. Most outcomes significantly increased
from hospitalisation to one month post-discharge. Time spent doing physical activity
(3 METs) increased from a mean  SD of 95  58 to 209  111 min.
Conclusions: Hospitalisation for an acute respiratory exacerbation was associated with less
time spent performing physical activity compared to one month post-discharge. Physical activ-
ity levels were higher than anticipated, even during hospitalisation, suggesting an increased
metabolic rate may have contributed to the physical activity levels documented. Activity level
definitions for moderate intensity exercise that are based on higher MET levels seemed more
appropriate in this patient setting.
Clinical trial registry: Australian New Zealand Clinical Trials Registry Number:
ACTRN12610000595011.
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patients with CF during and one month after hospitalisationExercise intolerance is one of the main sequelae of the
systemic effects of cystic fibrosis (CF). Higher physical ac-
tivity levels have been shown to be associated with slower
decline in pulmonary function, improved participation in
activities of daily living and quality of life, and reduced
hospital admissions for patients with CF.1,2 Furthermore,
aerobic exercise has been shown to improve pulmonary
function in patients with CF who are hospitalised with an
acute respiratory exacerbation compared to standard
care.3 Therefore, participation in formal exercise is one of
the minimum standards of care for patients with CF.4
Despite its perceived importance, there has been rela-
tively little research evaluating the physical activity levels
of this patient group. This paucity of research may be due,
at least partially, to difficulties measuring physical activity
levels and energy expenditure, with simple outcome mea-
sures (e.g. activity diaries, interviews, questionnaires)
having variable correlation with direct measures,5 and
more complex outcome measures (e.g. indirect calorim-
etry) being impractical outside of the laboratory setting.
However, relatively new, portable, lightweight devices,
such as the SenseWear Pro3 armband (Bodymedia, Pitts-
burgh, US), can be used to accurately measure physical
activity levels and energy expenditure. Dwyer et al. showed
that the SenseWearPro3 armband provided an accurate
estimate of energy expenditure for patients with stable CF,
although it over-estimated energy expenditure at low ex-
ercise intensities and under-estimated energy expenditure
at high exercise intensities.6
Previous research using the SenseWear armband has
shown that during periods of wellness adult patients with
CF have significantly reduced moderate or higher intensity
physical activity levels compared to age-matched controls.7
This is an important finding since it is generally acknowl-
edged that physical activity at moderate intensity has an
important long-term protective effect on health.8 Other
studies involving patients with CF have shown that physical
activity levels are lower in patients with an acute respira-
tory exacerbation compared to stable patients,9 and energy
expenditure is reduced during hospitalisation for an acute
respiratory exacerbation compared to one month post-
discharge.10 Pitta et al., investigating 17 patients with
chronic obstructive pulmonary disease, found reduced
physical activity levels during hospitalisation which per-
sisted for up to one month post-discharge.11
Whilst it is hypothesised that physical activity levels of
patients with CF will be reduced during hospitalisation for
an acute respiratory exacerbation and increase after
discharge, this has not been formally evaluated. Formal
evaluation of the physical activity levels of adult patients
with CF during and after a period of hospitalisation for an
acute respiratory exacerbation would provide valuable
baseline data for clinicians and assist in the design of future
studies investigating the most effective way to improve
physical activity levels during and after hospitalisation.
Therefore, the primary aim of this study was to measure
the physical activity levels of adult patients with CF during
hospitalisation for an acute respiratory exacerbation and at
one month post-discharge.12 The secondary aims were tomeasure exercise tolerance and muscle strength of adult
for an acute respiratory exacerbation.
Methods
Design
A prospective observational study was undertaken where
physical activity levels were measured for a 24-h period
between days 3e5 of the period of hospitalisation and
repeated one month after discharge. The study was
approved by the Royal Adelaide Hospital Research Ethics
Committee, registered with the Australian New Zealand
Clinical Trials Registry and supported by a Royal Adelaide
Hospital Allied Health Research Grant.
Setting and participants
The study was conducted at the Royal Adelaide Hospital, a
650-bed, tertiary care, urban, public hospital in Australia,
from October 2010 until February 2012. The Royal Adelaide
Hospital Adult CF Service currently cares for 165 patients.
Potential participants included adults (aged  18 years)
with CF who were admitted to the Royal Adelaide Hospital
with an acute respiratory exacerbation as clinically diagnosed
by their treating respiratory physician based on patient’s
symptoms and signs (e.g. changes in sputum volume/colour/
consistency, shortness of breath, fatigue, weight loss, dete-
rioration in spirometry/oxygenation, chest Xray findings).
Exclusion criteria were patients unwilling to participate, un-
able to commit to the one month follow-up measurements,
with a musculoskeletal condition adversely affecting physical
activity or whose medical condition was considered terminal.
Study protocol
Potential participants were approached regarding partici-
pation in the study between days 1 and 3 of hospitalisation
by an investigator (NW, DW, HR). Informed written consent
was obtained from those willing to participate.
All participants received standard medical, nursing and
allied health care during and after their hospital admission.
This care did not change as a result of participation in the
study. Standard care included intravenous treatmentwith two
different antibiotics, typically for 10e14 days, of which part
may have been completed at home. Systemic corticosteroids
were not routinely used. Advice regarding physical activity
was provided by CF physiotherapists as per normal practice.
For all patients, physical activity included encouragement to
walk for at least 20 min daily. Patients also had the option of
accessing an in-roomexercisebikeand supervisedattendance
at a nearby gym area within the hospital where various types
of exercise equipment were available (e.g. treadmill, exer-
cise bike, rowing machine, multigym and free weights).
Outcomes
The primary outcome was the time spent performing
physical activity. This was recorded over a 24-h period using
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hospitalisation and again one month after hospital
discharge. Days 3e5 were chosen for the timing of the
measures taken during the period of hospitalisation in order
to allow the patient’s condition to stabilise and provide
sufficient time to obtain informed written consent. The
data provided by the SenseWear Pro3 monitor included:
total energy expenditure, total physical activity duration,
time lying down and sleep duration, and time spent in
sedentary/moderate/vigorous/very vigorous activity based
on the metabolic equivalent of task (MET) values. Two
definitions for activity levels based on METs were used and
reported: the default settings used by the SenseWear Pro3
software, which are based on the American College of
Sports Medicine guidelines, and those used by Troosters
et al.7,13
Secondary outcomes were the modified shuttle walk test
and grip strength. The modified shuttle walk test is a
maximal exercise field test that has been shown to have
acceptable levels of reliability, repeatability and sensi-
tivity, and is commonly used to assess exercise tolerance
for patients with CF, including during hospitalisation.14 Grip
strength was measured using a calibrated Jamar dyna-
mometer on setting 2 to ensure maximal grip strength.15
Grip strength was measured as an indication of general
musculoskeletal strength, rather than strength of a weight
bearing muscle (e.g. quadriceps), in order to exclude the
potential impact of muscle weakness induced by reduced
weight bearing activities versus weakness induced by the
acute exacerbation. The modified shuttle walk test and grip
strength measurements were performed in a standardised
fashion between days 3 and 5 of hospitalisation and one
month after discharge. To ensure the physical activity
associated with these tests did not impact on the primary
outcome, these measures were not undertaken whilst the
SenseWear Pro3 armband was in situ.
Sample size
While this was an observational study, a sample size
calculation was undertaken based on the difference in
minutes of moderate level physical activity between the
period of hospitalisation and one month post-discharge,
with the effect size expressed as the mean difference
divided by the standard deviation (SD) of the difference. In
order to have 80% power to detect an effect size of 0.6 or
greater, using a 2-tailed p-value of 0.05 to indicate statis-
tical significance, a total of 24 patients was required.
Statistical analyses
Data were retrieved from the SenseWear Pro3 armband
using the product’s software. Data were entered onto an
Excel spreadsheet, checked for accuracy and cleaned
prior to analyses by study investigators. Only data from
patients who completed the primary outcome measure at
both time points (i.e. during hospitalisation and one
month following discharge) were included in analyses.
Frequency histograms for the main outcomes were visually
inspected and data were normally distributed. Differences
in the primary and secondary outcomes between the timepoints were analysed using paired samples t tests. Sta-
tistical analyses were performed using SPSS (Graduate
Pack 11.0 for Windows). Additionally, linear regression
models were fitted to the data to analyse the association
between baseline characteristics and changes in the main
outcomes from baseline to follow-up, using SAS V9.2 (SAS
Institute Inc.). P values of less than 0.05 were considered
significant.
Results
Flow of participants
Between October 2010 and February 2012, 67 patients were
screened for eligibility, 36 met the inclusion criteria and
were recruited. Twenty-four of these had the primary
outcome measured at both time points and were therefore
included in analyses. Flow of participants through the trial
and reasons for exclusion and non-completion are shown in
Fig. 1. Baseline demographic data for the 24 participants
who completed the study are shown in Table 1. All patients
were breathing spontaneously on room air.
Compliance with the trial method
SenseWear Pro3 armband data were obtained on both
measurement occasions from all 24 participants. Follow-up
data scheduled for one month after hospital discharge were
not always able to be completed at exactly one month,
primarily due to participants being unable to attend due to
other commitments. The mean (SD; range) follow-up period
was 33.7 days (5.4; 26e44). The modified shuttle walk test
was completed initially by 22 participants and at the one
month follow-up by 20 participants. Grip strength was
measured initially and at follow-up by 23 and 24 partici-
pants respectively.
Outcomes
Data obtained for physical activity levels, the modified
shuttle walk test and grip strength during the period of
hospitalisation and one month following discharge are
shown in Table 2. The amount of sedentary activity signif-
icantly decreased from admission to one month following
discharge, with a concomitant significant increase in overall
physical activity over time.
Linear regression analyses revealed that change scores
(baseline to follow-up) for total energy expenditure, time
spent doing physical activity (3 METs) and distance
covered in the modified shuttle walk test were not signifi-
cantly affected by age, admission forced expiratory volume
in 1 s or body mass index (p > 0.25). However, sex signifi-
cantly influenced the change in total energy expenditure,
with females having on average a 355 calories smaller in-
crease in total energy expenditure compared to males (95%
confidence interval [CI]: 56 to 654; pZ 0.02). Females also
had, on average, a 78 min smaller increase in time spent
doing physical activity (3 METs) compared to males, which
approached statistical significance (95% CI: 2 to 157;
p Z 0.055). Sex did not significantly affect the change in
Patients with cystic fibrosis 
admitted to hospital
n= 67
Eligible n= 37
Excluded n = 30
Unwilling to participate n = 14
Unable to commit to follow-up n = 5
Non-respiratory reason for admission n = 4
Musculoskeletal condition n = 1
Early discharge n = 5
Severely unwell n = 1
Recruited n= 36
Not recruited n =1
No device available n =1
Completed study n= 24
Did not complete study n =12
Failed to attend re-assessment n = 6
Did not tolerate armband n = 3
Musculoskeletal pain n = 1
Device malfunction n = 1
Readmitted in <1 month n = 1
Figure 1 Recruitment of participants.
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(p Z 0.90).Discussion
This observational study investigated the physical activity
levels, exercise tolerance and muscle strength of adult
patients with CF during and after hospitalisation for
an acute respiratory exacerbation. As hypothesised, all
measures showed improvement between the period of
hospitalisation and one month post-discharge, with most
achieving statistical significance.
Using the same MET levels, our findings at one month
post-discharge are comparable to those of Troosters et al.,
who investigated 20 adults with stable CF who were at
least six weeks post-exacerbation, for the mean times
spent doing mild and vigorous physical activity (mild:
163 min in our study vs. 130 min in Troosters et al.;
vigorous: 3 min in our study vs. 4 min in Troosters et al.).7
However, at one month post-discharge our sample recor-
ded a mean of 43 min of moderate physical activity,
considerably greater than the 15 min reported by Troosters
et al.7 This finding is surprising, particularly since our
sample, unlike that of Troosters et al., were still recov-
ering from an acute respiratory exacerbation and one
would therefore have hypothesised that they would be lessactive.7 Comparing our results to Van Remoortel et al., the
mean times spent in moderate physical activity in our
study (150 during hospitalisation and 430 one month post-
discharge) were considerably greater than those reported
by Van Remoortel et al. (medians of 3 min of moderate
intensity physical activity [activity level definitions were
not provided]) for 10 patients with CF during an acute
respiratory exacerbation and 14 min for 15 patients with
stable CF).9 The reason for this discrepancy in results is not
clear. However, it is possible that the physiotherapy
management of our patients, which focuses on the pro-
motion of physical activity, may have contributed to the
longer duration of moderate levels of physical activity seen
in our sample. Alternatively, it may be that patients who
agreed to participate in the study were more motivated to
undertake physical activity than non-participants, thus
biasing our sample.
As we had anticipated, most measures of physical activity
significantly improved between hospital admission and one
month post-discharge. However, we were surprised at the
overall amount of physical activity (3 METs) recorded
during the period of hospitalisation (mean Z 95 min) and
also at one month (meanZ 209 min), with both of these far
exceeding the recommended 30 min of physical activity per
day.13 While this may have been the result of participation in
formal exercise sessions (supervised or unsupervised), our
clinical impression is that this was unlikely and instead may
Table 2 Mean  SD (range) for all outcomes during hospitalisa
During hospital
Time spent doing physical activity, minutes
<3 METs (i.e. sedentary) 1326  51 (122
3 METs 95  58 (4e2
ACSM MET levels13
3e6 METs (moderate) 93  56 (4e2
6e9 METs (vigorous) 2  3 (0e8
> 9 METs (very vigorous) 0  0 (0e0
Troosters et al. MET levels7
3e4.8 METs (mild) 80  43 (4e1
4.8e7.2 METs (moderate) 15  21 (0e7
> 7.2 METs (vigorous) 0.4  1 (0e5
Total energy expenditure, calories 2047  366 (149
Time spent lying down, minutes, 575  133 (353
Time spent sleeping, minutes 427  114 (98e
Distance covered in the modified shuttle
walk test, metres
911  328 (460
Grip strength, kilograms,
Left 33  12 (13e
Right 36  12 (14e
SD e standard deviation; METs e metabolic equivalent of task; ACSM
Table 1 Baseline characteristics of the 24 participants.
Characteristic
Sex, n male (%) 15 (63)
Age, mean  SD
(range) (years)
28.3  8.4 (18e48)
Body mass index,
mean  SD (range)
20.5  2.2 (16e27)
Best FEV1 in previous 12 months,
mean  SD (range)
Litresa 2.48  0.98 (0.95e4.26)
% predicteda 63.9  19.8 (34e97)
Number of hospital admissions in previous 12 months, n (%)
0 4 (17)
1 11 (46)
2 2 (8)
3 5 (21)
4 2 (8)
Days since previous hospital
admission, median (range)a
203 (50e1480)
FEV1 on admission,
mean  SD (range)
Litresb 2.06  0.79 (0.80e3.73)
% predictedb 53.0  16.2 (28e84)
Length of hospital stay, days,
mean  SD (range)
10.6  3.5 (4e17)
Home intravenous antibiotics
following discharge, yes, n (%)
9 (38)
SD e standard deviation; FEV1 e forced expiratory volume in
1 s.
a n Z 23.
b n Z 20.
1018 N. Ward et al.have been influenced by other factors. Firstly, it may reflect
that patients had higher than normal resting metabolic rates
as a result of their respiratory exacerbation, meaning that
mild physical activity (3-6METs) was recorded even with
relatively minimal exertion (e.g. airway clearance, walking
around the ward). Previous research has demonstrated that
most patients with stable CF have an increased resting en-
ergy expenditure compared to normal subjects, which can
be further increased during an acute respiratory exacer-
bation.16e21 Secondly, as noted earlier, the SenseWear Pro
3 armband has been shown to over-estimate energy expen-
diture at lower exercise intensities in patients with stable
CF.6 Therefore, our results suggest that using 3 METs as the
lower threshold for definingmoderate physical activity when
using the SenseWear Pro 3 armband in the adult CF popu-
lation is too low, particularly when acutely unwell, with
higher MET levels (i.e. 4.8 METS as per Troosters et al.) being
more appropriate.7
With respect to our other findings, it is of interest that
there was no significant change in the distance covered in
the modified shuttle walk test between hospitalisation
and one month follow-up, whereas we had anticipated
this would increase over time. The reason for this is not
clear, particularly as participants had increased the mean
time spent performing moderate physical activity. An
implication of this finding is that exercise testing can be
undertaken either towards the end of the period of hos-
pitalisation or within a month of discharge without
significantly affecting the result. Whilst a significant in-
crease was seen in grip strength between the two time
points, the magnitude of this would not be considered
clinically important. We also noted that the time spent
lying down and the time spent sleeping did not signifi-
cantly change between hospitalisation and one monthtion and one month after discharge.
admission One month after discharge p-values
1e1401) 1191  118 (984e1428) <0.001
19) 209  111 (3e411) <0.001
12) 197  108 (3e398) <0.001
) 12  11 (0e41) <0.001
) 0.1  0.3 (0e1) 0.16
88) 163  93 (3e341) <0.001
0) 43  30 (0e121) <0.001
) 3  5 (0e18) 0.19
2e2890) 2452  560 (1535e3677) <0.001
e991) 546  111 (300e763) 0.40
644) 406  103 (214e601) 0.43
e1500) 917  323 (440e1500) 0.38
57) 35  11 (16e59) <0.001
63) 38  11 (18e64) <0.001
e American College of Sports Medicine.
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expressed as a proportion of the time spent lying down,
did not change between hospitalisation and one month
post-discharge (74% on both occasions). In our experi-
ence, patients with CF often report that they sleep poorly
whilst hospitalised, however, our findings do not support
this.
Our study has important clinical implications. Patients in
this study appeared to have a higher than normal resting
metabolic rate. Whilst additional exercise is likely to be
beneficial in terms of cardiovascular fitness and airway
clearance,1e4 it will further increase nutritional re-
quirements in a population where this is already a chal-
lenge and may adversely affect weight maintenance or
gain. Furthermore, the effect of exercise on systemic
inflammation, particularly during an acute respiratory
exacerbation, requires investigation.
Our study had a number of limitations, including a
reasonably high number who were excluded (30/67, 45%)
or failed to complete the study (12/36, 33%). However,
the participants who completed the study seemed
representative of patients who attend our Adult CF Ser-
vice in terms of their age and disease severity. Further-
more, data that were available for the 12 patients who
did not complete the study, whilst not formally analysed
due to its limited quantity, were similar to those who
completed the study. Nevertheless, we acknowledge that
this relatively high non-completion rate limits the gen-
eralisability of our results. We also acknowledge that it
may have been preferable to have collected the Sense-
Wear Pro3 armband data over a longer period of time,
however, this may have led to a higher drop-out rate.
Ideally, to gain a clearer picture of the effect of hospi-
talisation for an acute respiratory exacerbation on phys-
ical activity levels, it would have been preferable to have
compared the period of hospitalisation with a period of
wellness just preceding the onset of the exacerbation,
in addition to one month post-discharge. However, this
was clearly not possible given that hospitalisation for
acute respiratory exacerbations cannot be accurately
predicted.
Further research should be undertaken to confirm the
findings of this study regarding the most appropriate
physical activity level definitions to use in this patient
setting. Additionally, studies could be undertaken to
compare the effect of different types of exercise regi-
mens during the period of hospitalisation for an acute
exacerbation on physical activity levels for adult pa-
tients with CF. While increasing the amount of physical
activity that patients undertake whilst hospitalised
may be seen as desirable, it will also be important
that future studies consider the effect of increased
physical activity on energy requirements and systemic
inflammation.
In conclusion, we found that physical activity levels,
exercise tolerance and muscle strength were all reduced
during a period of hospitalisation for an acute respiratory
exacerbation compared to one month post-discharge for
adult patients with CF. Physical activity levels were
considerably higher than anticipated, indicating that ac-
tivity level definitions based on higher MET levels may be
more appropriate for this patient population.Acknowledgement
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